Nifekalant unmasked residual gap of superior vena cava isolation by suppressing immediate recurrence of intra-superior vena cava fibrillation.

Nifekalant successfully suppressed intra-superior vena cava fibrillation, which complicated the evaluation of the gap of superior vena cava isolation.